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Abstract
Background: Atopic diseases are a major burden of disease on a global scale. Regarding their aetiology, the early
years of life are assumed to play a crucial role. In addition, there is growing evidence that elucidating the impact of
cross-generational effects and epigenetic mechanisms such as DNA methylation can substantially widen the
scientific knowledge of the occurrence and progression of these diseases. We are thus aiming at following the
course of asthma, allergies, and potential risk factors for their occurrence across three generations by establishing a
birth cohort in the offspring of an existing population-based cohort.
Methods/Design: 2051 young adults who have been recruited in 1995 for Phase II of the International Study of
Asthma and Allergies in Childhood (ISAAC) and who have subsequently been followed-up by the Study on
Occupational Allergy Risks (SOLAR) are asked bi-annually since 2009 if they conceived a child in the meantime. If
parenthood is reported, parents are invited to enrol along with their children in the ACROSSOLAR cohort.
Participation involves completing a questionnaire assessing general and health-related information about the
course of the pregnancy and the first year of life of their children. Subsequently, the children are followed up until
primary school age when asthma and allergies can be diagnosed reliably. In addition, DNA for epigenetic analysis
will be collected and analysed. Longitudinal data analysis techniques will then be used to assess potential
associations between early-life exposures and onset of childhood asthma and allergies taking into account
epigenetics.
Discussion: Birth cohorts are especially suited to elucidate the impact of genetic predisposition, epigenetics,
exposures during the first years of life, and gene-environment interactions on the occurrence and progression of
asthma and allergies. By building upon an existing cohort, ACROSSOLAR offers a unique and cost-effective
opportunity to investigate the aetiology of atopic disease in a prospective and cross-generational way.
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Background
Atopic diseases such as asthma, allergic rhinitis, and
atopic dermatitis are the most frequent illnesses among
children and adolescents with about one in four children
being affected [1, 2]. Their prevalence varies consider-
ably across different regions and populations [3–5].
While asthma and allergies have traditionally been
regarded as morbidities of high-income countries, an in-
crease in their prevalence has recently been observed in
low- and middle-income countries – a fact that might
lead to severe public health problems for the affected re-
gions [2, 6–8]. Moreover, these diseases are also causing
substantial economic costs, both in terms of direct costs
such as treatments costs and indirect costs such as re-
duction of work productivity [9, 10].
Concerning the aetiology of these diseases, the current
state of knowledge assumes that they are caused by a
complex interaction between genetic and environmental
factors such as pre- and postnatal maternal smoking or
exposure to damp and mould [11–16]. These interac-
tions are understood to be especially powerful during
the prenatal period and the first years of life [17–23].
Therefore, these early years are a crucial period when in-
vestigating potential risk factors for asthma and allergies.
Such investigations should be especially done under con-
sideration of epigenetic mechanisms as these constitute
a novel and promising approach to further disentangle the
origin and progression of asthma and allergies [24–27].
Out of several potential epigenetic markers, DNA methy-
lation is the most prominent and most frequently investi-
gated one [24, 26–28]. Regarding asthma, there is notable
evidence for an association of DNA methylation with vari-
ous asthma-related phenotypes [29–31]. However, the role
of DNA methylation during asthma development as well
as underlying biological mechanisms requires further elu-
cidation [26, 32]. Birth cohort studies following the role of
DNA methylation prospectively and across generations
are the ideal approach to answer these questions [26].
The cross-generational aspect is especially intriguing
since there is some first indication of an effect not only
of maternal exposures but also of grandmaternal expo-
sures, especially smoking, on subsequent diseases in the
offspring [33–36]. Such effects across three generations
are also assumed to be mediated by epigenetic modifica-
tions [37–39]. Further investigating these aspects can
substantially increase the understanding of the aetiology,
treatment, and prevention of asthma and allergies [37].
The ACROSSOLAR (Atopic Childhood Disease Risk
Factors in the Second Generation of the SOLAR Partici-
pants) project described here thus aims at establishing a
prospective population-based birth cohort that collects
information across three generations. To achieve this
aim, the study builds upon an existing cohort which has
been recruited for the German branch of Phase II of the
International Study of Asthma and Allergies in Child-
hood (ISAAC) and in the meantime has been followed
up twice by the Study on Occupational Allergy Risks
(SOLAR) [40–45]. This approach provides the unique
opportunity to assess the effects of genetic predispos-
ition, epigenetic factors, and environmental factors such
as exposure to environmental tobacco smoke, living con-
ditions, and parental occupation in a prospective and
cross-generational study. Accordingly, the main objec-
tives of ACROSSOLAR are:
 To investigate the incidence of childhood asthma
and allergies across three generations
 To analyse the association between early-life expos-
ure to potential risk factors such as maternal smok-
ing, maternal stress, or grandmaternal smoking and
the incidence of childhood asthma and allergies
 To analyse the impact of epigenetic mechanisms
such as DNA methylation on the occurrence of
asthma and allergies across generations
The present paper describes the design of the
ACROSSOLAR project giving concise and detailed infor-
mation on the study population, recruitment methods,
and study instruments. Furthermore, the challenges in
the study design are discussed.
Methods/Design
Study design
ACROSSOLAR is a prospective birth cohort study in-
cluding the members of an already existing cohort and
their children.
Study population
The cohort was recruited originally for the German
branch of Phase II of the International Study of
Asthma and Allergies in Childhood (ISAAC) [40, 45].
Between 1995 and 1996, a random sample of 7489
children aged nine to eleven years was drawn from
the population registries in the cities of Dresden and
Munich. Parents of 6399 children (85.3 %) completed
a questionnaire on demographic, health-related, and
environmental factors. Main outcomes of interest
were wheezing, atopic rhinitis, and eczema while the
potential risk factors included birthweight, gestational
age, breast feeding, family size, family history of dis-
eases, vaccinations, environmental tobacco smoke,
physical activity, nutrition, and many more [45]. A
sub-sample of the participating children underwent
diagnostic tests for asthma symptoms and atopic sen-
sitisation such as skin prick tests (N = 4578), skin
examination (N = 4941), bronchial challenges with
hypertonic saline (N = 2188), lung function test (N =
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2589), and measurements of specific and total serum
immunoglobulin E (IgE) levels (N = 3823) [41, 45, 46].
Those families who had agreed to be contacted again
were invited to take part in the first follow-up, the Study
on Occupational Allergy Risks (SOLAR), between 2002
and 2003. In total, 3929 adolescents aged 16 to 18 years
were included. Using questions from ISAAC Phase II
and the European Community Respiratory Health Sur-
vey [47], the study examined the course of asthma and
atopy and their association with environmental as well
as occupational factors such as current state of employ-
ment, jobs held during holidays, and the type of job sub-
jects would like to have in the future (preferred job
choice) [41, 48]. The jobs indicated by the study subjects
were coded according to the International Standard
Classification of Occupations-88 [49] and an asthma-
specific job exposure matrix was used to classify them as
nonexposed jobs, low-risk jobs, and high-risk jobs de-
pending on the level of exposure to potential asthma risk
factors [50].
When they were aged 19 to 24 years, 2051 participants
took part in the second follow-up, SOLAR II (2007–2009)
[42]. Fifty-seven percent of them not only answered the
study questionnaire but also underwent clinical examin-
ation (including assessment of anthropometric data, blood
pressure measurement, skin prick test, patch test, and
lung function test). Compared to the previous survey,
SOLAR II collected additional information on family sta-
tus, parenthood, work-related stress, hand eczema, and
exposure to cleaning sprays, disinfectants, fumes, and gas.
SOLAR II mainly aimed at analysing various potential pre-
dictors of work-related sensitisation, allergic rhinitis, and
asthma in early work life [43, 44].
The 2051 SOLAR II participants of whom 58 % are fe-
male constitute the eligible population for participating
in the ACROSSOLAR study. Figure 1 provides an over-
view of the course of follow-up from ISAAC Phase II to
ACROSSOLAR.
Recruitment process
Starting in 2009, SOLAR II participants are asked in a
bi-annual manner via e-mail if they had conceived a
child and, if this is the case, if they are willing to take
part in the ACROSSOLAR study. Upon agreement, they
then receive an ACROSSOLAR package by mail contain-
ing an invitation letter, an informed consent form, and
the study questionnaire. To maximise response, we also
provide the opportunity to complete the questionnaire
electronically via SurveyMonkey (SurveyMonkey Inc.,
Portland, USA). Therefore, a link to the online version
of the questionnaire is sent to the participants in
addition to the paper version. As another means of en-
hancing participation, two postal reminders are sent to
non-responders. If participants report parenthood but
indicate that they do not want to join ACROSSOLAR,
they are not contacted any further.
SOLAR II participants for whom we do not have a
valid email address receive a postal invitation together
with the informed consent form and the questionnaire.
Those participants who changed their residence in the
meantime are tracked via the population registry.
The first invitations were sent out in October and No-
vember 2009. From SOLAR II it was known that 44 par-
ticipants already had a child – the ACROSSOLAR
package including the postal and the electronic ques-
tionnaire was thus sent out to them directly. 1444
people for whom an email address was available from
SOLAR II received an email asking if they conceived a
child in the meantime. Those who reported parenthood
and agreed to take part in ACROSSOLAR were then en-
rolled and received the paper and electronic version of
the questionnaire. This procedure was repeated in No-
vember 2010 when another email was sent to those who
had not reported parenthood or had not responded in
2009 (N = 1231). The latest period of recruitment was in
2012, when those who had not responded or did not
have children so far received another invitation to report
parenthood and to enrol in the ACROSSOLAR cohort
(Fig. 2). The remaining 563 SOLAR II participants with
no valid e-mail address available received the postal
package including the invitation letter, the informed con-
sent form and the questionnaire during the above men-
tioned recruitment phases in 2010 and 2012. The next
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Fig. 1 Flow chart of follow-up from ISAAC Phase II to ACROSSOLAR indicating time periods, number of participants, participants’ age, and phase
of life
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Sample size
By January 2015, 108 parents completed the paper or
electronic version of the questionnaire (73 from Dresden
and 35 from Munich). However, the participants were
still relatively young when the recruitment for ACROSS-
OLAR started (aged 21 to 26 years) while in Germany
the mean age for giving birth to the first child is esti-
mated to be 29 years [51]. Accordingly, 60 % of the new-
borns are conceived by women in the age group between
26 and 35 years [52]. As the majority of the 2051
SOLAR participants will enter that age group during the
study period we are expecting a number of about 1000
new-borns being eligible for participation. Based on the
experience with SOLAR I and II, we are confident that
we can achieve a response rate of 80 %. Hence, we ex-
pect the number of returned questionnaires to increase
to a total of N = 800. For the power calculations, we esti-
mate the prevalence for the main outcome wheezing
during the first year of life to lie between 15 and 30 %
[8, 53–55], while for the exposure variables (e.g. mater-
nal smoking, maternal stress, grandmaternal smoking)
we are reckoning with a prevalence of about 10 %. With
80 % power our sample will then allow us to detect rela-




The questionnaire involves sections asking for informa-
tion regarding the child as well as its parents and grand-
parents. Regarding the child, the questionnaire captures
the following information: birth of the child (date of
birth, birth weight, type of delivery), medical history in
the first year of life and during follow-up in the subse-
quent years of life (asthma symptoms, diagnosis of air-
way diseases or atopic dermatitis, intake of medication),
breastfeeding (duration of breastfeeding, type of milk
used as supplements), and living conditions (number of
persons in the household, whereabouts of the child dur-
ing the day). In each family, the questionnaire is only
completed for one child. Those participants who already
have more than one child are asked to complete the
questionnaire for the youngest one.
The maternal section of the questionnaire asks for the
mother’s general health (asthma diagnosis and asthma
symptoms, allergies, atopic dermatitis), medical history
during pregnancy (infections, gestational diabetes, intake
of medication), and smoking. The paternal section is ad-
dressed to those fathers who had not participated in
SOLAR II (i.e., the mother of the child is a member of
the original cohort) and collects information on symp-
toms or diagnosis of asthma, bronchitis, hay fever, or
atopic dermatitis, as well as intake of medication and
smoking.
In addition, demographic data (age, education, occupa-
tional status, number of children) are recorded for that
parent who did not take part in SOLAR II. Moreover,
life-time prevalence of asthma, bronchitis, hay fever, and
atopic dermatitis among the grandparents of the chil-
dren is assessed by the questionnaire.
When the children are in primary school age (six to
nine years of age), the parents will be asked to complete
the questionnaire again. By then, it will be possible to
perform a first reliable diagnosis of asthma and atopic
dermatitis.
All sections are based on validated questionnaires that
have been successfully used in previous studies such as
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Fig. 2 Process of recruitment of those participants with a valid
email address
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the German Multicentre Allergy Study [56] and the
PASTURE project (Protection against Allergy - STUdy
in Rural Environments) [57].
Clinical examination
In addition to the questionnaire data, we aim to invite
the children and their parents to a clinical examination
when the children are in primary school age. This will
involve lung function test and blood sampling. Lung
function measurements will be conducted in accordance
with the guidelines of the American Thoracic Society
[58]. Blood samples will be used for epigenetic analyses
and for measurement of total immunoglobulin E (IgE)
levels as a test for allergic sensitisation. For analysis of
IgE levels, we will use the same procedure as in SOLAR
II [42].
Regarding epigenetics, peripheral CD-4+ T cells will be
isolated using magnetic cell sorting and isolation kits.
DNA will be stored frozen at −80 °C and will be isolated
with the FlexiGene DNA Kit (Qiagen NV, Venlo,
Netherlands). For array-based DNA methylation ana-
lysis, 800 ng of genomic DNA will be treated with so-
dium bisulfite using the EZ-96 DNA Methylation Kit
(Zymo Research Corporation, Irvine, USA). The Infi-
nium HumanMethylation450 BeadChip Kit (Illumina
Inc., San Diego, USA) will then be used for measure-
ment of genome-wide DNA methylation. After genome-
wide amplification of 4 μl of bisulfite-treated DNA and
enzymatic fragmentation, the samples will be added to
the chip. The fraction or percent methylation will be re-
ported as Beta-value. This value is expressed as a con-
tinuous variable between 0 and 1 corresponding to the
ratio of methylated molecules to the sum of methylated
and unmethylated molecules [59].
Data management
Data will be stored and handled at the Institute and Out-
patient Clinic for Occupational, Social and Environmen-
tal Medicine, University Hospital of Munich (LMU),
Munich, Germany. Data from the paper version of the
questionnaire will be entered into a password-protected
MS Access database (Microsoft Corporation, Redmond,
USA). Double data entry will be used to detect and re-
duce errors. For further analysis, these data will be com-
bined with the questionnaire data that participants
directly entered into the SurveyMonkey database. To
make full use of all the data collected since 1995, the
ACROSSOLAR dataset will also be merged with the
datasets of the previous studies (ISAAC II and SOLAR I
and II) using a unique study ID.
Statistical analysis
First, descriptive statistics will outline the characteristics
of the study sample. Bivariate analyses will then evaluate
potential associations between the exposure and outcome
variables that are included in the study questionnaire.
Next, statistical methods for analysis of longitudinal data
such as Poisson regression and logistic regression models
will be used for further examination of possible associa-
tions [60, 61]. Potential confounders will be included in
the model if they change the effect estimates for the asso-
ciation between the exposure and outcome variables by at
least ten percent (change-in-estimate criterion) [62]. To
address the problem of missing data, we will run multiple
imputations using the R-package Amelia II (The R Foun-
dation for Statistical Computing, Vienna, Austria) which
performs expectation-maximization with bootstrapping
algorithms [63–65].
Regarding epigenetic analyses, CpG sites that are
within 50 bp to known SNPs or in allosomal positions
will be removed. For each chip, colour bias adjustment
using quantile normalisation and background correction
based on a negative control will be performed using the
R-package lumi [66]. Further analyses will be carried out
with a random intercepts mixed model approach.
Ethics
The questionnaire part of the study was approved by the
Ethical Committee of the Medical Faculty of the Univer-
sity of Dresden, Dresden, Germany. An amendment re-
garding the epigenetic sampling will be requested in due
time.
Discussion
Atopic diseases not only continue to have a high preva-
lence in high-income countries, but they are also gaining
importance in low- and middle-income countries. They
are thus a substantial burden of disease on a global scale.
At the same time, it is still not fully understood so far
which factors contribute to their development. What has
been shown rather reliably is that genetic predisposition,
exposures during the first years of life, epigenetic mecha-
nisms, and gene-environment interactions may be cru-
cial. Research aiming at precisely disentangling their role
is thus urgently needed and requires innovative
methods. Birth cohorts are an approach that is especially
suited to tackle this issue [67]. They allow investigating
the effect of genetic and environmental factors as well as
their interactions on the course of atopic diseases from
the early life years onwards.
The ACROSSOLAR study presented here provides the
unique opportunity to establish such a birth cohort in
the offspring of an existing cohort. Including the parent
generation, ACROSSOLAR can also benefit of a wide
range of detailed socio-demographic, occupational, and
health-related data on the parents and even grandpar-
ents of the children that have already been collected dur-
ing several follow-ups. It is thus possible to follow the
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course of atopic diseases and potential risk factors across
three generations. Another strength of our approach is
that not only do we build upon the experience and infra-
structure of ISAAC phase II and SOLAR phases I and II
but also that the ACROSSOLAR questionnaire is based
on validated instruments that have been successfully
used in similar projects [56, 57]. Providing a web-based
version of the questionnaire is another asset of our study
since it has been shown that it becomes increasingly
popular among participants to complete surveys online
[68]. Also the SurveyMonkey software itself was success-
fully utilised in previous medical research projects [69–71].
Moreover, integrating epigenetic analysis, namely DNA
methylation of isolated CD-4+ T cells, across genera-
tions will offer the unparalleled opportunity to inves-
tigate underlying mechanisms of asthma development
in an unique way.
Regarding potential limitations of our approach, there
is some indication from SOLAR II that subjects with
higher educational level, higher levels of health con-
sciousness, and higher likelihood of atopic diseases were
more likely to participate [42]. This means that the ori-
ginal cohort on which the ACROSSOLAR birth cohort
is based might be affected by some form of selection to-
wards higher educated people with higher risk of suffer-
ing from asthma or allergies. It seems plausible that the
same effect might apply to participation in ACROSSO-
LAR. On the other side, this could be counterbalanced
by the effect that people with lower educational levels
conceive children earlier than higher educated people so
that more families with lower educational status will
enrol into the birth cohort. In any case, the potential of
selection bias will be carefully taken into account when
analysing and interpreting the collected data. Having
said that, it is much more important for the validity of
the results in prospective cohort studies to maintain a
high level of internal validity [72]. In this context, a pos-
sibly more severe form of bias could be introduced by
loss to follow-up, especially if it differs between exposed
and unexposed subjects [73]. Therefore, maximal effort
will be spent to keep loss to follow-up as low as possible,
e.g. by sending out two reminders to non-respondents at
each phase of follow-up. The same applies to the issue
of generalisability: One might argue that especially from
a geographic or socio-economic point of view our sam-
ple is a rather homogenous group that can hardly be
compared with populations in low- and middle-income
settings. We are albeit confident that our findings will
help to advance the understanding of the underlying bio-
logic principles so that our sample would nevertheless
be “biologically representative” [62]. In the past, many
important and valid conclusions have been drawn from
cohorts that were not geographically representative
whatsoever [72, 74].
Another challenge of our study will be to accurately
coordinate the enrolment and follow-up of participants
as the two will run in parallel. This complex approach
requires significant administrative and organisational ef-
forts throughout the study. However, as already men-
tioned we are building upon the experience and
equipment from ISAAC Phase II and SOLAR as well as
other large-scale research projects in the field of asthma
and allergies.
To conclude, the ACROSSOLAR project offers the
unique opportunity to build a birth cohort among the
children of an existing large-scale cohort. It allows fol-
lowing the course of asthma, allergic diseases, and a
wide range of potential risk factors and underlying
mechanisms including epigenetics in a prospective and
cross-generational way. The study can thus substantially
contribute to further enhance the understanding about
the determinants of these diseases.
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